Robert J. Adelman

Robert J. Adelman

Founder at
venBio Partners LLC

Net worth: 188 871 $ as of 31/05/2026

63 year
Health Technology
Commercial Services
Consumer Services

Profile

Robert J.
Adelman
is the founder of Veritas Medicine, Inc. (founded in 1999) and venBio Partners LLC (founded in 2009) where he holds the title of Managing Partner.
Dr. Adelman is also the founder of QIAGEN Operon, Inc., Sientra, Inc...
Dr. Adelman's current job is as a Director at ALX Oncology, Inc. Dr. Adelman's former jobs include being a Director at Philips Image Guided Therapy Corp., Cerimon Pharmaceuticals, Inc., Innovative Spinal Technologies, Inc., ViewRay Technologies, Inc., Precision BioSciences, Inc., Apellis Pharmaceuticals, Inc., Solstice Biologics LLC, Turning Point Therapeutics, Inc., ARYx Therapeutics, Inc., CryoCor, Inc., Mirna Therapeutics, Inc., Aragon Pharmaceuticals, Inc., Heart Metabolics Ltd., Seragon Pharmaceuticals, Inc., Metacrine, Inc., Sorrento Tech, Inc., Labrys Biologics, Inc., and Partner at OrbiMed Advisors Private Equity.
Dr. Adelman's education includes a doctorate from Yale University and an undergraduate degree from the University of California, Berkeley.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
0.07%
02/02/2026 99,406 ( 0.07% ) 188 871 $ 31/05/2026

Robert J. Adelman active positions

CompaniesPositionStart
Founder 01/06/2009
Director/Board Member -

Former positions of Robert J. Adelman

CompaniesPositionEnd
METACRINE, INC. Director/Board Member 17/03/2021
PRECISION BIOSCIENCES, INC. Director/Board Member 08/11/2019
Private Equity Investor 31/05/2010
Director/Board Member 02/03/2009
ARYX THERAPEUTICS, INC. Director/Board Member 05/02/2009
See the detail of Robert J. Adelman's experience

Training of Robert J. Adelman

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

44

1st degree connections

25

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies25

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Technology Services

Health Technology

Finance

Commercial Services

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Robert J. Adelman